These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q. Naia L; Ribeiro MJ; Rego AC Rev Neurosci; 2011 Dec; 23(1):13-28. PubMed ID: 22150069 [TBL] [Abstract][Full Text] [Related]
3. Update on Huntington's disease: advances in care and emerging therapeutic options. Zielonka D; Mielcarek M; Landwehrmeyer GB Parkinsonism Relat Disord; 2015 Mar; 21(3):169-78. PubMed ID: 25572500 [TBL] [Abstract][Full Text] [Related]
4. Pridopidine for the treatment of Huntington's disease. Shannon KM Expert Opin Investig Drugs; 2016; 25(4):485-92. PubMed ID: 26881734 [TBL] [Abstract][Full Text] [Related]
5. Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials? Bates GP; Hockly E Curr Opin Neurol; 2003 Aug; 16(4):465-70. PubMed ID: 12869804 [TBL] [Abstract][Full Text] [Related]
6. Surveying the landscape of Huntington's disease mechanisms, measurements, and medicines. Crook ZR; Housman DE J Huntingtons Dis; 2013; 2(4):405-36. PubMed ID: 25062729 [TBL] [Abstract][Full Text] [Related]
7. An update on Huntington's disease: from the gene to the clinic. Kim SD; Fung VS Curr Opin Neurol; 2014 Aug; 27(4):477-83. PubMed ID: 24978638 [TBL] [Abstract][Full Text] [Related]
17. [Current perspectives in the treatment of Huntington's chorea]. Kuran W Neurol Neurochir Pol; 2002; 36(4):757-65. PubMed ID: 12418139 [TBL] [Abstract][Full Text] [Related]